The AHA, American Society of Health-System Pharmacists, American Society of Anesthesiologists, Institute for Safe Medication Practices, and American Society of Clinical Oncology today urged the Drug Enforcement Administration to temporarily adjust the aggregate production quotas for certain injectable opioid medications in short supply to allow other manufacturers to supply product until the shortages resolve. “We understand and share the DEA’s concern that these medications need to be well‐managed and used judiciously to help stem the nation’s opioid epidemic,” the organizations wrote. “We fully support and use advances in pain management, such as multimodal analgesia, that enable patients to undergo procedures with fewer opioids and less reliance on opioids after surgery. Nonetheless, injectable opioids remain a crucial component of patient management during and immediately after many operations. With no appropriate opioids available, operations would have to be postponed or cancelled. In some cases, this could prove life‐threatening to the patient.”
 

Related News Articles

Headline
The Department of Homeland Security has released a new resource to help hospitals and health systems prepare for and respond to an active shooter incident.
Chairperson's File
During Mental Health Month, let’s all remember that caring for the whole person improves health and saves lives.
Headline
The AHA Physician Alliance today released a resource to help hospital and health system leaders address burnout in their organizations.
Headline
The AHA has elected to fill a vacancy on its Board of Trustees Sylvia Young, president and CEO of HCA Healthcare’s Continental Division.
Headline
A new AHA issue brief describes how hospitals are investing in affordable housing, based on initial findings from the Accelerating Investments for Healthy…
Headline
The AHA May 16 at 11 a.m. ET will host a Twitter chat as part of National Hospital Week to honor and discuss the many ways that hospital employees provide hope…